ストックスクリーナーアプリを入手
3.13
1.88%
-0.06
アフターアワーズ：
3.13
前日終値:
$3.19
開ける：
$3.21
24時間の取引高:
499.83K
Relative Volume:
0.62
時価総額：
$310.43M
収益：
$69.56M
当期純損益:
$-240.05M
株価収益率:
-1.061
EPS:
-2.95
ネットキャッシュフロー:
$-121.90M
1週間 パフォーマンス:
+16.79%
1か月 パフォーマンス:
-3.69%
6か月 パフォーマンス:
+95.62%
1年 パフォーマンス:
+6.83%
1日の値動き範囲:
$3.095
$3.24
1週間の範囲:
$2.605
$3.24
52週間の値動き範囲:
$1.05
$3.97
Adc Therapeutics Sa Stock (ADCT) Company Profile
ADCT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
3.13 | 358.87M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-08 | 開始されました | Stephens | Overweight |
| 2024-05-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-03-28 | 開始されました | Guggenheim | Buy |
| 2023-08-10 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-04-24 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-12-06 | 開始されました | CapitalOne | Overweight |
| 2022-11-09 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-09-21 | 開始されました | JP Morgan | Overweight |
| 2022-09-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | 開始されました | Wolfe Research | Outperform |
| 2021-08-17 | 再開されました | Jefferies | Buy |
| 2021-08-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-06-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-12-03 | 開始されました | Stifel | Hold |
| 2020-10-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-06-09 | 開始されました | BofA/Merrill | Buy |
| 2020-06-09 | 開始されました | Cowen | Outperform |
すべてを表示
Adc Therapeutics Sa (ADCT) 最新ニュース
Cantor Fitzgerald Brokers Raise Earnings Estimates for ADCT - MarketBeat
ADC Therapeutics SA (NYSE:ADCT) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
ADC Therapeutics (NYSE:ADCT) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
ADC Therapeutics (NYSE:ADCT) Given "Buy" Rating at Guggenheim - MarketBeat
Is ADC Therapeutics SA the Top Chart Pick This WeekMarket Volume Summary & Free Weekly Watchlist of Top Performers - beatles.ru
Is It Too Late to Sell ADC Therapeutics SAWeekly Stock Report & Low Drawdown Momentum Trade Ideas - beatles.ru
ADC Therapeutics SA Approaches Psychological Resistance Level2025 Trading Volume Trends & Weekly Watchlist for Consistent Profits - sundaytimes.kr
Real Time Data Flags Unusual Activity in ADC Therapeutics SAJuly 2025 Fed Impact & High Conviction Buy Zone Picks - metal.it
ADC Therapeutics Reports Q2 2025 Financial Results: Earnings Breakdown and Strategic Maneuvers - AInvest
ADC Therapeutics (NYSE:ADCT) Announces Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update - BioSpace
ADC Therapeutics S.A. (NYSE:ADCT) Q2 2025 Earnings Call Transcript - Insider Monkey
ADC Therapeutics 2025 Q2 Earnings Deeper Losses Amid Revenue Growth - AInvest
MACD Cross Could Confirm Trend in ADC Therapeutics SA2025 Biggest Moves & Real-Time Buy Signal Notifications - metal.it
ADC Therapeutics SA (ADCT) Q2 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... By GuruFocus - Investing.com Canada
ADC Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts - MSN
Transcript : ADC Therapeutics SA, Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
ADC Therapeutics SA reports results for the quarter ended June 30Earnings Summary - TradingView
ADC Therapeutics SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
ADC Therapeutics Reports Second Quarter 2025 Financial Results - TradingView
Can ADC Therapeutics SA weather a recessionConsistent Triple Digit Profits - mustnews.co.kr
Using data models to predict ADC Therapeutics SA stock movementPortfolio Positioning Strategy With Timing - Newser
How to recover losses in ADC Therapeutics SA stockSafe Entry Screening with Data Backed Analysis - Newser
Can volume confirm reversal in ADC Therapeutics SASwing Trade Timing with Daily Forecast - Newser
Will ADC Therapeutics SA stock go up soonWeekly Hot Stocks Based on Volume Flow - Newser
Will ADC Therapeutics SA continue its uptrendFree Value Investing Picks With Stability - Newser
Pattern recognition hints at ADC Therapeutics SA upsideAlpha Trade Flow With Risk Calibration - Newser
Reversal Confirmed ADC Therapeutics SA Stock Rallies Above MALow Risk High Return Opportunities Identified - beatles.ru
Earnings visualization tools for ADC Therapeutics SAFree Weekly Return Pick Forecast Reports - Newser
Is ADC Therapeutics SA reversing from oversold territoryRSI and MACD Signal Summary with Trends - Newser
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025 - 富途牛牛
Bank of New York Mellon Corp Decreases Stock Holdings in ADC Therapeutics SA (NYSE:ADCT) - Defense World
What’s next for ADC Therapeutics SA stock pricePredictive Analytics for Equity Growth Potential - Newser
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - sharewise.com
What makes ADC Therapeutics SA stock price move sharplySmart Trade Mapping with Entry Details - Newser
Chondrosarcoma Market: Epidemiology, Pipeline Products, Companies Working, Delveinsight Aadi Bioscience Inc, Acrotech Biopharma LLC, ADC Therapeutics SA, Advenchen Laboratories LLC, Alkermes Plc, As - Menafn
How strong is ADC Therapeutics SA company’s balance sheetCapitalize on emerging growth stocks - Jammu Links News
What is ADC Therapeutics SA company’s growth strategyGet alerts on high-potential stock breakouts - Jammu Links News
How volatile is ADC Therapeutics SA stock compared to the marketMaximize portfolio value with expert tips - Jammu Links News
Does ADC Therapeutics SA stock perform well during market downturnsGet daily updates on top-performing stocks - Jammu Links News
Should I hold or sell ADC Therapeutics SA stock in 2025Achieve rapid growth with smart investments - Jammu Links News
What institutional investors are buying ADC Therapeutics SA stockConsistent triple-digit returns - Jammu Links News
What is the dividend policy of ADC Therapeutics SA stockUnlock exclusive trading strategies for gains - Jammu Links News
ADC Therapeutics (ADCT) to Release Quarterly Earnings on Tuesday - Defense World
Is ADC Therapeutics SA stock overvalued or undervaluedGet daily updates on promising stocks - Jammu Links News
Why ADC Therapeutics SA stock attracts strong analyst attentionEquity Forecast with Predictive AI Screener - Newser
How does ADC Therapeutics SA generate profit in a changing economyLightning-fast growth - Jammu Links News
What are the latest earnings results for ADC Therapeutics SAInvest smarter with actionable trading signals - Jammu Links News
What are ADC Therapeutics SA company’s key revenue driversUnlock high-yield investment opportunities - Jammu Links News
Adc Therapeutics Sa (ADCT) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):